News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,367 Results
Type
Article (87839)
Company Profile (824)
Press Release (779690)
Multimedia
Podcasts (189)
Webinars (28)
Section
Business (233194)
Career Advice (4144)
Deals (39853)
Drug Delivery (145)
Drug Development (91389)
Employer Resources (203)
FDA (18371)
Job Trends (17416)
News (397789)
Policy (39955)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (140)
Alliances (56981)
ALS (177)
Alzheimer's disease (1775)
Antibody-drug conjugate (ADC) (321)
Approvals (18529)
Artificial intelligence (596)
Autoimmune disease (145)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (488)
Bladder cancer (155)
Brain cancer (63)
Breast cancer (636)
Cancer (4839)
Cardiovascular disease (426)
Career advice (3566)
Career pathing (40)
CAR-T (297)
CDC (59)
Celiac Disease (1)
Cell therapy (802)
Cervical cancer (37)
Clinical research (76778)
Collaboration (1678)
Company closure (5)
Compensation (1107)
Complete response letters (68)
COVID-19 (2984)
CRISPR (94)
C-suite (792)
Cystic fibrosis (150)
Data (6044)
Decentralized trials (2)
Denatured (69)
Depression (138)
Diabetes (513)
Diagnostics (7194)
Digital health (43)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (290)
Drug pricing (213)
Drug shortages (36)
Duchenne muscular dystrophy (230)
Earnings (99932)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134827)
Executive appointments (1015)
FDA (21378)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (22)
Funding (1483)
Gene editing (205)
Generative AI (61)
Gene therapy (644)
GLP-1 (1101)
Government (5430)
Grass and pollen (8)
Guidances (381)
Healthcare (20941)
HIV (56)
Huntington's disease (47)
IgA nephropathy (85)
Immunology and inflammation (282)
Immuno-oncology (45)
Indications (80)
Infectious disease (3262)
Inflammatory bowel disease (200)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (229)
Interviews (816)
IPO (17949)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (654)
Leadership (39)
Legal (10156)
Liver cancer (97)
Longevity (14)
Lung cancer (661)
Lymphoma (368)
Machine learning (41)
Management (66)
Manufacturing (787)
MASH (170)
Medical device (14993)
Medtech (15037)
Mergers & acquisitions (22925)
Metabolic disorders (1337)
Multiple sclerosis (156)
NASH (23)
Neurodegenerative disease (332)
Neuropsychiatric disorders (91)
Neuroscience (3027)
NextGen: Class of 2026 (7706)
Non-profit (5107)
Now hiring (62)
Obesity (643)
Opinion (329)
Ovarian cancer (158)
Pain (194)
Pancreatic cancer (218)
Parkinson's disease (285)
Partnered (37)
Patents (482)
Patient recruitment (445)
Peanut (59)
People (66741)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23717)
Phase II (33308)
Phase III (25124)
Pipeline (4349)
Policy (325)
Postmarket research (3554)
Preclinical (10678)
Press Release (72)
Prostate cancer (236)
Psychedelics (53)
Radiopharmaceuticals (295)
Rare diseases (838)
Real estate (7437)
Recruiting (80)
Regulatory (28769)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (25)
RNA editing (17)
RSV (82)
Schizophrenia (155)
Series A (248)
Series B (182)
Service/supplier (30)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4330)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (97)
The Weekly (118)
Vaccines (1118)
Venture capital (86)
Weight loss (446)
Women's health (81)
Worklife (21)
Date
Today (193)
Last 7 days (661)
Last 30 days (2025)
Last 365 days (33377)
2026 (678)
2025 (33228)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (335)
Arkansas (14)
Asia (51444)
Australia (9029)
California (11102)
Canada (3227)
China (1107)
Colorado (467)
Connecticut (487)
Delaware (337)
Europe (118187)
Florida (1627)
Georgia (356)
Hawaii (3)
Idaho (68)
Illinois (923)
India (64)
Indiana (528)
Iowa (23)
Japan (408)
Kansas (131)
Kentucky (42)
Louisiana (29)
Maine (81)
Maryland (1421)
Massachusetts (8234)
Michigan (348)
Minnesota (641)
Mississippi (6)
Missouri (136)
Montana (35)
Nebraska (28)
Nevada (120)
New Hampshire (83)
New Jersey (3027)
New Mexico (32)
New York (2961)
North Carolina (1562)
North Dakota (10)
Northern California (5265)
Ohio (340)
Oklahoma (22)
Oregon (53)
Pennsylvania (2237)
Puerto Rico (20)
Rhode Island (49)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4271)
Tennessee (171)
Texas (1758)
United States (40324)
Utah (333)
Vermont (1)
Virginia (279)
Washington D.C. (85)
Washington State (937)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
There are 868,367 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
January 8, 2026
·
3 min read
Press Releases
Agomab Announces Positive Phase 1 Interim Results with AGMB-447 in Healthy Participants and Initiation of Idiopathic Pulmonary Fibrosis Cohort
January 8, 2026
·
4 min read
Press Releases
Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
January 8, 2026
·
4 min read
Press Releases
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
January 8, 2026
·
1 min read
Press Releases
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
January 8, 2026
·
6 min read
Press Releases
Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD
January 8, 2026
·
2 min read
Press Releases
NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson’s
January 8, 2026
·
3 min read
Press Releases
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
January 8, 2026
·
12 min read
Press Releases
Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors
January 8, 2026
·
5 min read
Press Releases
EnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome
January 8, 2026
·
5 min read
1 of 86,837
Next
